Medical Procedures
Explore procedure pages with patient-friendly context about preparation, expectations, and recovery.
All medical procedures (122,362)
Other
aPTT.factor substitution 2H post incubation with normal plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution 2H post incubation with normal plasma in Platelet poor plasma from Control by Coagulation assay
Other
aPTT.factor substitution 5 minutes post incubation after addition of normal plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution 5 minutes post incubation after addition of normal plasma in Platelet poor plasma from Control by Coagulation assay
Other
aPTT.factor substitution immediately after 1:1 addition of normal plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution immediately after 1:4 addition of normal plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution immediately after 1:4 addition of normal plasma in Platelet poor plasma from Control by Coagulation assay
Other
aPTT.factor substitution immediately after addition of factor IX depleted plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution immediately after addition of factor V depleted plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution immediately after addition of factor V depleted plasma+APC in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution immediately after addition of factor XI depleted plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution immediately after addition of factor XII depleted plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution immediately after addition of factor XIII depleted plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution immediately after addition of normal plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution immediately after addition of normal plasma in Platelet poor plasma from Control by Coagulation assay
Other
aPTT.factor substitution with 1:1 Pooled Normal Plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution with normal plasma 1H post incubation separate tubes in Platelet poor plasma by Coagulation assay
Other
aPTT.factor substitution with normal plasma 2H post incubation separate tubes in Platelet poor plasma by Coagulation assay
Other
aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay
Other
aPTT.lupus insensitive in Platelet poor plasma by Coagulation assay
Other
aPTT.lupus sensitive (LA screen)
Other
aPTT.lupus sensitive W excess phospholipid (LA confirm)
Other
aPTT.lupus sensitive W excess phospholipid actual/Normal (normalized LA confirm)
Other
aPTT.lupus sensitive W excess phospholipid percent correction
Other
aPTT.lupus sensitive actual/normal (normalized LA screen)
Other
aPTT.lupus sensitive in Platelet poor plasma from Control by Coagulation assay
Other
aPTT.lupus sensitive post heparin neutralization in Platelet poor plasma by Coagulation assay
Other
aPTT.lupus sensitive with 1:1 PNP (LA mix)
Other
aPTT.lupus sensitive with 1:1 PNP actual/Normal (normalized LA mix)
Other
aPTT.lupus sensitive.excess phospholipid post heparin neutralization actual/normal in Platelet poor plasma by Coagulation assay
Other
aPTT.lupus sensitive.excess phospholipid post heparin neutralization in Platelet poor plasma by Coagulation assay
Other
aPTT.lupus sensitive.factor substitution 1H post incubation with 1:1 normal plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.lupus sensitive.factor substitution 2H post incubation with 1:1 normal plasma in Platelet poor plasma by Coagulation assay
Other
aPTT.lupus sensitive/aPTT.lupus sensitive W excess phospholipid (screen to confirm ratio)
Diagnostic
alpha-2-Macroglobulin measurement
alpha-2-Macroglobulin measurement — clinical procedure (SNOMED CT 104503001).
Diagnostic
alpha-Amino acid nitrogen measurement
alpha-Amino acid nitrogen measurement — clinical procedure (SNOMED CT 104498004).
Diagnostic
alpha-Amino-n-butyrate measurement
alpha-Amino-n-butyrate measurement — clinical procedure (SNOMED CT 104499007).
Diagnostic
alpha-Aminoadipate measurement
alpha-Aminoadipate measurement — clinical procedure (SNOMED CT 104500003).
Diagnostic
alpha-Chlordane measurement
alpha-Chlordane measurement — clinical procedure (SNOMED CT 121323006).
Diagnostic
alpha-Glucosidase measurement
alpha-Glucosidase measurement — clinical procedure (SNOMED CT 104505008).
Diagnostic
alpha-Hydroxyalprazolam measurement
alpha-Hydroxyalprazolam measurement — clinical procedure (SNOMED CT 121324000).
Diagnostic
alpha-Ketoglutarate measurement
alpha-Ketoglutarate measurement — clinical procedure (SNOMED CT 104506009).
Diagnostic
alpha-L-Iduronidase measurement, fibroblasts
alpha-L-Iduronidase measurement, fibroblasts — clinical procedure (SNOMED CT 80573008).
Diagnostic
alpha-L-Iduronidase measurement, leukocytes
alpha-L-Iduronidase measurement, leukocytes — clinical procedure (SNOMED CT 49753005).
Diagnostic
alpha-L-iduronidase measurement
alpha-L-iduronidase measurement — clinical procedure (SNOMED CT 25652006).
Diagnostic
alpha-Melanocyte stimulating hormone measurement
alpha-Melanocyte stimulating hormone measurement — clinical procedure (SNOMED CT 104507000).
Diagnostic
alpha-Naphthylesterase measurement
alpha-Naphthylesterase measurement — clinical procedure (SNOMED CT 104508005).
Diagnostic
alpha-Thymosin measurement
alpha-Thymosin measurement — clinical procedure (SNOMED CT 104509002).
Diagnostic
alpha>1< Antichymotrypsin measurement
alpha>1< Antichymotrypsin measurement — clinical procedure (SNOMED CT 104502006).
Diagnostic
alpha>2< Retinol binding protein measurement
alpha>2< Retinol binding protein measurement — clinical procedure (SNOMED CT 104504007).
Other
amLODIPine [Mass/mass] in Hair
Other
amLODIPine [Mass/volume] in Body fluid
Other
amLODIPine [Mass/volume] in Urine
Other
amLODIPine [Presence] in Urine
Other
b-wave amplitude Left retina dark-adapted by ERG
Other
b-wave amplitude Left retina light-adapted by ERG
Other
b-wave amplitude Right retina dark-adapted by ERG
Other
b-wave amplitude Right retina light-adapted by ERG
Other
b-wave implicit time Left retina dark-adapted by ERG
Other
b-wave implicit time Left retina light-adapted by ERG
Other
b-wave implicit time Right retina dark-adapted by ERG
Other
b-wave implicit time Right retina light-adapted by ERG
Diagnostic
beta-Alanine measurement
beta-Alanine measurement — clinical procedure (SNOMED CT 104542001).
Diagnostic
beta-Aminoisobutyrate measurement
beta-Aminoisobutyrate measurement — clinical procedure (SNOMED CT 104543006).
Diagnostic
beta-Endorphin measurement
beta-Endorphin measurement — clinical procedure (SNOMED CT 104544000).
Diagnostic
beta-Hydroxybutyrate dehydrogenase measurement
beta-Hydroxybutyrate dehydrogenase measurement — clinical procedure (SNOMED CT 104547007).
Diagnostic
beta-Lipoprotein measurement
beta-Lipoprotein measurement — clinical procedure (SNOMED CT 104785007).
Diagnostic
beta-Lipotropin measurement
beta-Lipotropin measurement — clinical procedure (SNOMED CT 104548002).
Diagnostic
beta-Melanocyte stimulating hormone measurement
beta-Melanocyte stimulating hormone measurement — clinical procedure (SNOMED CT 104549005).
Diagnostic
beta-gamma-Tocopherol measurement
beta-gamma-Tocopherol measurement — clinical procedure (SNOMED CT 121743002).
Other
buPROPion [Mass/mass] in Tissue
Other
buPROPion [Mass/volume] in Body fluid
Other
buPROPion [Mass/volume] in Urine
Other
buPROPion [Presence] in Urine
Other
buPROPion cutoff [Mass/volume] in Urine for Confirmatory method
Other
busPIRone [Mass/volume] in Urine
Other
c-MYC Oncoprotein Ag [Presence] in Tissue by Immune stain
Other
carBAMazepine [Mass/volume] in Body fluid
Other
carBAMazepine [Mass/volume] in DBS
Other
carBAMazepine [Mass/volume] in Urine
Other
carBAMazepine [Mass] of Dose
Other
carBAMazepine [Presence] in Gastric fluid
Other
carBAMazepine [Presence] in Specimen
Other
carBAMazepine [Presence] in Urine
Other
carBAMazepine free [Mass/volume] in Saliva (oral fluid)
Other
ceFAZolin [Mass/volume] in Specimen
Other
ceFAZolin [Mass/volume] in Urine
Other
ceFAZolin [Mass] of Dose
Other
ceFAZolin [Susceptibility]
Other
ceFAZolin [Susceptibility] by Disk diffusion (KB)
Other
ceFAZolin [Susceptibility] by Gradient strip
Other
ceFAZolin [Susceptibility] by Minimum inhibitory concentration (MIC)
Other
ceFAZolin [Susceptibility] by Minimum lethal concentration (MLC)
Other
ceFAZolin [Susceptibility] by Serum bactericidal titer
Other
ceFAZolin [Susceptibility] for UTI by Minimum inhibitory concentration (MIC)
Other
cefOXitin [Mass/volume] in Specimen
Other
cefOXitin [Mass] of Dose
Other
cefOXitin [Susceptibility]
Other
cefOXitin [Susceptibility] Qualitative
Other
cefOXitin [Susceptibility] by Disk diffusion (KB)